Chinese City Links H1N1 Flu Shot To Nerve Damage In 13-Year-Old Boy
This article was originally published in PharmAsia News
Executive SummaryA local Chinese health bureau believes the H1N1 flu vaccine a 13-year-old boy obtained may have led to his contracting acute disseminated encephalomyelitis, sources said
You may also be interested in...
Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.